Results 151 to 160 of about 1,211,683 (168)

Frequency and Magnitude of Co-payments Exceeding Prescription Drug Costs.

JAMA, 2018
Van Nuys K, Joyce G, Ribero R, Goldman DP.   +3 more
europepmc   +1 more source

Screening urged for hepatitis C but drug costs are prohibitive. [PDF]

CMAJ, 2014
Fralick M.
europepmc   +1 more source

Antiretroviral drug costs and prescription patterns in British Columbia, Canada: 1996-2011. [PDF]

Med Care, 2014
Nosyk B, Montaner JS, Yip B, Lima VD, Hogg RS, STOP HIVAIDS Study Group.   +5 more
europepmc   +1 more source

Burden of disease of Alzheimer disease in Italy: a real-world data analysis. [PDF]

BMC Health Serv Res
Mennini FS, Sciattella P, Scortichini M, Migliorini R, Trabucco Aurilio M, Marcellusi A, Bianchetti A.   +6 more
europepmc   +1 more source

Economic Impact of Elranatamab for Treatment of Patients with Relapsed or Refractory Multiple Myeloma. [PDF]

Clinicoecon Outcomes Res
Shah B, Sandin R, Liu Y, Bobolts LR, Hu Y, Mol I, Schepart A, Hughes DM, Hart J, Hlavacek P.   +9 more
europepmc   +1 more source

A systematic review of the current application status of decision-analytical models in the pharmacoeconomic evaluation of targeted therapies for pulmonary arterial hypertension. [PDF]

Cost Eff Resour Alloc
Dong W, Zhang Z, Wang X, Ma X, Chu M, Li Y, Xiang X, Peng C, Zhang R.   +8 more
europepmc   +1 more source

Cost analysis of the TB-PRACTECAL clinical trial on novel tuberculosis treatment regimens. [PDF]

PLOS Glob Public Health
Gotham D, Martin M, Barber MJ, Kazounis E, Batts C, Scourse R, Elder G, Nyang'wa BT.   +7 more
europepmc   +1 more source

Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries. [PDF]

Pulm Circ
Kjellström B, Ivarsson B, Husberg M, Levin LÅ, Bernfort L.   +4 more
europepmc   +1 more source